SCHEMBL3420494

SCHEMBL3420494

COC(OC)[SiH2]C.N=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2472458 0.82
SCHEMBL3420600 0.72 THRB (0.33)
Methoxymethane SCHEMBL5410419 0.67
Methoxymethane SCHEMBL9757875 0.67
SCHEMBL1048304 0.67
SCHEMBL8491516 0.67
SCHEMBL28399324 0.65
SCHEMBL7749209 0.63
SCHEMBL9188135 0.61
Isobutane SCHEMBL3986587 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115380081-B Curable composition 株式会社钟化 2024-05-24 CN disclosed
EP-4303258-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2024-01-10 EP disclosed
CN-113166395-B Polyoxyalkylene polymer and curable composition 株式会社钟化 2024-01-05 CN disclosed
CN-113423794-B Curable composition 株式会社钟化 2023-12-08 CN disclosed
US-20230323089-A1 CURABLE COMPOSITION KANEKA NORTH AMERICA LLC (US) 2023-10-12 US disclosed
WO-2021059972-A1 CURABLE COMPOSITION 株式会社カネカ 2021-04-01 WO disclosed
US-10954419-B2 Curable composition KANEKA CORPORATION (JP) 2021-03-23 US disclosed
WO-2021024817-A1 CURABLE COMPOSITION 株式会社カネカ 2021-02-11 WO disclosed
US-20210024723-A1 CURABLE COMPOSITION KANEKA NORTH AMERICA LLC (US) 2021-01-28 US disclosed
EP-3608365-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2020-02-12 EP disclosed
EP-3342819-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2018-07-04 EP disclosed
EP-3165572-A1 CURABLE COMPOSITION AND CURED OBJECT OBTAINED THEREFROM Kaneka Corporation (JP) 2017-05-10 EP disclosed
US-20170114209-A1 CURABLE COMPOSITION KANEKA NORTH AMERICA LLC (US) 2017-04-27 US disclosed
US-20170107374-A1 CURABLE COMPOSITION AND CURED OBJECT OBTAINED THEREFROM KANEKA CORPORATION (JP) 2017-04-20 US disclosed
US-20160160010-A1 CURABLE COMPOSITION KANEKA NORTH AMERICA LLC (US) 2016-06-09 US disclosed
US-8962716-B2 Curable composition KANEKA CORPORATION (JP) 2015-02-24 US disclosed
US-8815985-B2 Curable composition KANEKA CORPORATION (JP) 2014-08-26 US disclosed
US-20130116378-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2013-05-09 US disclosed
US-20100152373-A1 CURABLE COMPOSITION KANEKA CORPORATION (JP) 2010-06-17 US disclosed
EP-2119745-A1 CURABLE COMPOSITION Kaneka Corporation (JP) 2009-11-18 EP disclosed